INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update
The Board of International Biotechnology Trust plc (the "Company") notes the following change to the value of the unquoted portfolio company Archemix.
The Directors' valuation of the holding in this unquoted portfolio company has been decreased today from £811k to £538k to reflect a change in the focus of the business' drug development. This valuation change will be incorporated into the net asset value ("NAV") of the Company from today and reflected in the Company's NAV announcements with effect from tomorrow, 16 February 2010.
Enquiries:
Kate Bingham/David Pinniger
Telephone: 020 7412 7070
SV Life Sciences Managers LLP
Investment Manager
Rachael Nelson
Telephone: 020 7410 3132
BNP Paribas Secretarial Services Limited
Company Secretary
15 FEBRUARY 2010